Anthony T. Reder to Dose-Response Relationship, Drug
This is a "connection" page, showing publications Anthony T. Reder has written about Dose-Response Relationship, Drug.
Connection Strength
0.303
-
Inhibition of interferon-beta responses in multiple sclerosis immune cells associated with high-dose statins. Arch Neurol. 2012 Oct; 69(10):1303-9.
Score: 0.081
-
Cross-sectional study assessing long-term safety of interferon-beta-1b for relapsing-remitting MS. Neurology. 2010 Jun 08; 74(23):1877-85.
Score: 0.069
-
Combining beta interferon and atorvastatin may increase disease activity in multiple sclerosis. Neurology. 2008 Oct 28; 71(18):1390-5.
Score: 0.060
-
Varicella-zoster virus infections in patients treated with fingolimod: risk assessment and consensus recommendations for management. JAMA Neurol. 2015 Jan; 72(1):31-9.
Score: 0.024
-
Regulation of production of adrenocorticotropin-like proteins in human mononuclear cells. Immunology. 1992 Nov; 77(3):436-42.
Score: 0.020
-
Interferon-gamma and tumour necrosis factor induce expression of major histocompatibility complex antigen on rat retinal astrocytes. Br J Ophthalmol. 1991 Aug; 75(8):473-5.
Score: 0.019
-
Long-term follow-up of the original interferon-beta1b trial in multiple sclerosis: design and lessons from a 16-year observational study. Clin Ther. 2009 Aug; 31(8):1724-36.
Score: 0.016
-
Neutralizing antibodies to interferon beta: assessment of their clinical and radiographic impact: an evidence report: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2007 Mar 27; 68(13):977-84.
Score: 0.014